Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0941820140240040265
Korean Journal of Clinical Pharmacy
2014 Volume.24 No. 4 p.265 ~ p.271
Consumer Perspectives on the Informed Consent of Off-label Drug Use in South Korea
Lee Iyn-Hyang

Kye Seung-Hee
Je Nam-Kyung
Lee Suk-Hyang
Abstract
Objective: This study aims to explore the perception of off-label use of medications and the provision of informed consents
from the general public¡¯s perspective.

Methods: The study subjects (n=291) were recruited from 7 cities in Korea through a convenience sampling method. The self-administered questionnaire with 13 items was issued and collected. The study subjects who have had a pharmaceutical job were excluded.

Results: The total of 231 respondents was included. Only 23% of respondents were familiar with the concept of off-label use of medications. Eighty five percent of respondents (n=196) stated that the prescribers should explain the off-label use of a medication to their patients. The preferred method for delivering the message was the oral explanation (n=122, 53%), followed by oral explanation plus a pamphlet (n=94, 41%). The safety issue is the most concerned aspect regarding the off-label drug use, also effectiveness and insurance coverage. The majority of respondents (n=217, 94%) agreed that the prescriber should get a consent from patients before prescribing medications for off-label use. They preferred written consent to oral consent (140 vs. 77).

Conclusion: This study demonstrated general publics are infrequently aware of off-label use of medications. It is important to raise public awareness of the off-label use of medications and to openly discuss its pros and cons for safe and effective drug therapy.
KEYWORD
off-label drugs, informed consent, safety, risk management
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)